According to the 2 industry analysts covering Ensysce Biosciences, the consensus is that breakeven is near. They anticipate the company to incur a final loss in 2025, before generating positive ...

Pharmaceutical manufacturers may need new models to maintain sustainable businesses and support patients who cannot afford ...

The empowerment of patients yields several benefits from the potential of increased uptake of preventative care measures to ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

The AP-NORC survey shows about half of U.S. adults believe it is a good thing for adults to use Ozempic, Wegovy and similar ...

While it's next to impossible to know how many opioids entered the state illegally in 2023, we do know that just under 1.7 ...

Online pharmacies will need a proper consultation, not just a patient's questionnaire, to prescribe jabs such as Mounjaro ...

Those too slim to be eligible for injections can no longer get prescription without seeing a doctor under new guidance ...

Minnesota Senator Amy Klobuchar is urging the Trump administration to continue negotiating lower prescription drug prices for ...

The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.

About 80 million Americans fill prescriptions each year for medications to treat new instances of moderate to severe pain, ...

You can find discounts on a variety of prescription drugs by searching GoodRx, but the ones compiled on the 30 under $30 ...